Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Filings indexed 271 across all filing types
Latest filing 2025-10-31 Regulatory Filings
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항 (유한양행의 얀센바이오테크 기술이전 마일스톤 분배)
Regulatory Filings
2025-10-31 Korean
주주총회소집결의 (임시주주총회)
Regulatory Filings
2025-10-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2025-10-22 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정) (면역성 혈소판감소증(ITP)의 1차 치료법 가능성에 대한 탐색적 2상 연구자 주도 임상시험 IND 승인)
Regulatory Filings
2025-09-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it falls under the general regulatory announcement category for corporate events.
2025-08-18 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '오스코텍' (Oscotec) covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, business operations, management discussions, and financial statements, which are characteristic of an interim/quarterly report. It is not a mere announcement or certification, as it provides substantive financial data and operational details. H1 2025
2025-08-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.